QIAGEN N.V. announced the launch of its next-generation automated nucleic acid purification platform, QIAsymphony Connect, at the AMP 2025 Annual Meeting in Boston, designed...
Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases
QIAGEN announced it has signed a definitive agreement to acquire...
Ingenuity Pathway Analysis Interpret extends analysis capabilities of human-curated knowledge base with AI technology.
QIAGEN announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a...
QIAGEN announced the release of a new version of its clinical decision support software, QIAGEN Clinical Insight Interpret (QCI Interpret), that brings significant performance...
QIAGEN announced the availability of QCI Secondary Analysis, a cloud-based software-as-a-services (SaaS) solution enabling high-throughput secondary analysis for use with any clinical next-generation sequencing...
QIAGEN and Element Biosciences, Inc. announced a strategic partnership to offer comprehensive next-generation sequencing (NGS) workflows for the Element AVITI™ System, an innovative sequencing...